← SynDRA
ANTAZOLINE
SynDRA canonical compound SYN0005157 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | HRH1 |
|---|
| Mechanism of action | Antihistamine |
|---|
| Indication | conjunctivitis | nasal congestion |
|---|
| Disease area | ophthalmology | otolaryngology |
|---|
All known targets
Mechanisms of action (all sources)
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- SLC6A3
- ADRA1A
- ADRA2A
- PDE3A
- PDE4D
- PDE6A
- DRD2
- KCNH2
- LMNA
- NPY2R
- NPY1R
- MLNR
- MC4R
- MC3R
- MAOA
- ACHE
- KMT2A
- NTSR1
- KDM4E
- HTR7
- HTR6
- HTR5A
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- NR3C1
- OPRM1
- OPRD1
- SLCO1B3
- TSHR
- TDP1
- TBXA2R
- TACR2
- TACR1
- TAAR1
- SMPD1
- SMAD3
- SLC6A4
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Allergic Agents
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Neurotransmitter Agents
- Antihistamine
ATC classes
- R01A · DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- VASOCON-A
- antazoline mesylate
- antazoline sulfate
- phenazoline
- antazoline phosphate
- antazoline hydrochloride
- antazoline HCl
- Antazolina
- Atazoline
- Antaz sulf
- Vasocon-a
- Analergine
- Antastan
- Antasten
- Antazolin
- Antazolinum
- Antihistal
- Antistin
- Antistine
- Azalone
- Histostab;Imidamin
- Imidamine
- Phenazolin
- Phenazoline
- Antazolina [Spanish]
- Antazolinum [Latin]
- Antazolina [INN-Spanish]
- Antazoline (INN)
- Antazoline [INN:BAN]
- Antazolinum [INN-Latin]
- Ben-A-hist
- 2-(N-Benzylanilinomethyl)-2-imidazoline
- 2-(N-Phenyl-N-benzylaminomethyl)imidazoline
- 2-Phenyl-benzyl-amino-methylimidazolin
- 2-Phenyl-benzyl-amino-methylimidazolin [German]
- 5512-M
- Histostab
- DHA8014SS1
Look up ANTAZOLINE in the interactive SynDRA portal →